Export Ready — 

Cholesteryl hemiazelate identified in CVD patients causes in vitro and in vivo inflammation

Bibliographic Details
Main Author: Domingues, Neuza S.
Publication Date: 2023
Other Authors: Gaifem, Joana, Matthiesen, Rune, Saraiva, Diana P., Bento, Luís, Marques, André R. A., Soares, Maria I. L., Sampaio, Julio, Klose, Christian, Surma, Michal A., Almeida, Manuel Lopes de, Rodrigues, Gustavo, Gonçalves, Pedro Araújo, Ferreira, Jorge, E Melo, Ryan Gouveia, Pedro, Luís Mendes, Simons, Kai, Melo, Teresa M. V. D. Pinho e, Cabral, M. Guadalupe, Jacinto, António, Silvestre, Ricardo, Vaz, Winchil L. C., Vieira, Otília V.
Format: Article
Language: eng
Source: Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
Download full: https://hdl.handle.net/10316/111997
https://doi.org/10.1016/j.jlr.2023.100419
Summary: Oxidation of PUFAs in LDLs trapped in the arterial intima plays a critical role in atherosclerosis. Though there have been many studies on the atherogenicity of oxidized derivatives of PUFA-esters of cholesterol, the effects of cholesteryl hemiesters (ChEs), the oxidation end products of these esters, have not been studied. Through lipidomics analyses, we identified and quantified two ChE types in the plasma of CVD patients and identified four ChE types in human endarterectomy specimens. Cholesteryl hemiazelate (ChA), the ChE of azelaic acid (n-nonane-1,9-dioic acid), was the most prevalent ChE identified in both cases. Importantly, human monocytes, monocyte-derived macrophages, and neutrophils exhibit inflammatory features when exposed to subtoxic concentrations of ChA in vitro. ChA increases the secretion of proinflammatory cytokines such as interleukin-1β and interleukin-6 and modulates the surface-marker profile of monocytes and monocyte-derived macrophage. In vivo, when zebrafish larvae were fed with a ChA-enriched diet, they exhibited neutrophil and macrophage accumulation in the vasculature in a caspase 1- and cathepsin B-dependent manner. ChA also triggered lipid accumulation at the bifurcation sites of the vasculature of the zebrafish larvae and negatively impacted their life expectancy. We conclude that ChA behaves as an endogenous damage-associated molecular pattern with inflammatory and proatherogenic properties.
id RCAP_33e05bab4b69b7ac4285b5a71250b180
oai_identifier_str oai:estudogeral.uc.pt:10316/111997
network_acronym_str RCAP
network_name_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository_id_str https://opendoar.ac.uk/repository/7160
spelling Cholesteryl hemiazelate identified in CVD patients causes in vitro and in vivo inflammationcholesteryl hemiesterscholesteryl hemiazelateslipidomicsinnate inflammatory responsesatherosclerosisAnimalsHumansCholesterol EstersMonocytesInflammationEstersZebrafishAtherosclerosisOxidation of PUFAs in LDLs trapped in the arterial intima plays a critical role in atherosclerosis. Though there have been many studies on the atherogenicity of oxidized derivatives of PUFA-esters of cholesterol, the effects of cholesteryl hemiesters (ChEs), the oxidation end products of these esters, have not been studied. Through lipidomics analyses, we identified and quantified two ChE types in the plasma of CVD patients and identified four ChE types in human endarterectomy specimens. Cholesteryl hemiazelate (ChA), the ChE of azelaic acid (n-nonane-1,9-dioic acid), was the most prevalent ChE identified in both cases. Importantly, human monocytes, monocyte-derived macrophages, and neutrophils exhibit inflammatory features when exposed to subtoxic concentrations of ChA in vitro. ChA increases the secretion of proinflammatory cytokines such as interleukin-1β and interleukin-6 and modulates the surface-marker profile of monocytes and monocyte-derived macrophage. In vivo, when zebrafish larvae were fed with a ChA-enriched diet, they exhibited neutrophil and macrophage accumulation in the vasculature in a caspase 1- and cathepsin B-dependent manner. ChA also triggered lipid accumulation at the bifurcation sites of the vasculature of the zebrafish larvae and negatively impacted their life expectancy. We conclude that ChA behaves as an endogenous damage-associated molecular pattern with inflammatory and proatherogenic properties.Elsevier2023-09info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttps://hdl.handle.net/10316/111997https://hdl.handle.net/10316/111997https://doi.org/10.1016/j.jlr.2023.100419eng00222275Domingues, Neuza S.Gaifem, JoanaMatthiesen, RuneSaraiva, Diana P.Bento, LuísMarques, André R. A.Soares, Maria I. L.Sampaio, JulioKlose, ChristianSurma, Michal A.Almeida, Manuel Lopes deRodrigues, GustavoGonçalves, Pedro AraújoFerreira, JorgeE Melo, Ryan GouveiaPedro, Luís MendesSimons, KaiMelo, Teresa M. V. D. Pinho eCabral, M. GuadalupeJacinto, AntónioSilvestre, RicardoVaz, Winchil L. C.Vieira, Otília V.info:eu-repo/semantics/openAccessreponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiainstacron:RCAAP2024-07-23T15:37:36Zoai:estudogeral.uc.pt:10316/111997Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireinfo@rcaap.ptopendoar:https://opendoar.ac.uk/repository/71602025-05-29T06:04:20.106291Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiafalse
dc.title.none.fl_str_mv Cholesteryl hemiazelate identified in CVD patients causes in vitro and in vivo inflammation
title Cholesteryl hemiazelate identified in CVD patients causes in vitro and in vivo inflammation
spellingShingle Cholesteryl hemiazelate identified in CVD patients causes in vitro and in vivo inflammation
Domingues, Neuza S.
cholesteryl hemiesters
cholesteryl hemiazelates
lipidomics
innate inflammatory responses
atherosclerosis
Animals
Humans
Cholesterol Esters
Monocytes
Inflammation
Esters
Zebrafish
Atherosclerosis
title_short Cholesteryl hemiazelate identified in CVD patients causes in vitro and in vivo inflammation
title_full Cholesteryl hemiazelate identified in CVD patients causes in vitro and in vivo inflammation
title_fullStr Cholesteryl hemiazelate identified in CVD patients causes in vitro and in vivo inflammation
title_full_unstemmed Cholesteryl hemiazelate identified in CVD patients causes in vitro and in vivo inflammation
title_sort Cholesteryl hemiazelate identified in CVD patients causes in vitro and in vivo inflammation
author Domingues, Neuza S.
author_facet Domingues, Neuza S.
Gaifem, Joana
Matthiesen, Rune
Saraiva, Diana P.
Bento, Luís
Marques, André R. A.
Soares, Maria I. L.
Sampaio, Julio
Klose, Christian
Surma, Michal A.
Almeida, Manuel Lopes de
Rodrigues, Gustavo
Gonçalves, Pedro Araújo
Ferreira, Jorge
E Melo, Ryan Gouveia
Pedro, Luís Mendes
Simons, Kai
Melo, Teresa M. V. D. Pinho e
Cabral, M. Guadalupe
Jacinto, António
Silvestre, Ricardo
Vaz, Winchil L. C.
Vieira, Otília V.
author_role author
author2 Gaifem, Joana
Matthiesen, Rune
Saraiva, Diana P.
Bento, Luís
Marques, André R. A.
Soares, Maria I. L.
Sampaio, Julio
Klose, Christian
Surma, Michal A.
Almeida, Manuel Lopes de
Rodrigues, Gustavo
Gonçalves, Pedro Araújo
Ferreira, Jorge
E Melo, Ryan Gouveia
Pedro, Luís Mendes
Simons, Kai
Melo, Teresa M. V. D. Pinho e
Cabral, M. Guadalupe
Jacinto, António
Silvestre, Ricardo
Vaz, Winchil L. C.
Vieira, Otília V.
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Domingues, Neuza S.
Gaifem, Joana
Matthiesen, Rune
Saraiva, Diana P.
Bento, Luís
Marques, André R. A.
Soares, Maria I. L.
Sampaio, Julio
Klose, Christian
Surma, Michal A.
Almeida, Manuel Lopes de
Rodrigues, Gustavo
Gonçalves, Pedro Araújo
Ferreira, Jorge
E Melo, Ryan Gouveia
Pedro, Luís Mendes
Simons, Kai
Melo, Teresa M. V. D. Pinho e
Cabral, M. Guadalupe
Jacinto, António
Silvestre, Ricardo
Vaz, Winchil L. C.
Vieira, Otília V.
dc.subject.por.fl_str_mv cholesteryl hemiesters
cholesteryl hemiazelates
lipidomics
innate inflammatory responses
atherosclerosis
Animals
Humans
Cholesterol Esters
Monocytes
Inflammation
Esters
Zebrafish
Atherosclerosis
topic cholesteryl hemiesters
cholesteryl hemiazelates
lipidomics
innate inflammatory responses
atherosclerosis
Animals
Humans
Cholesterol Esters
Monocytes
Inflammation
Esters
Zebrafish
Atherosclerosis
description Oxidation of PUFAs in LDLs trapped in the arterial intima plays a critical role in atherosclerosis. Though there have been many studies on the atherogenicity of oxidized derivatives of PUFA-esters of cholesterol, the effects of cholesteryl hemiesters (ChEs), the oxidation end products of these esters, have not been studied. Through lipidomics analyses, we identified and quantified two ChE types in the plasma of CVD patients and identified four ChE types in human endarterectomy specimens. Cholesteryl hemiazelate (ChA), the ChE of azelaic acid (n-nonane-1,9-dioic acid), was the most prevalent ChE identified in both cases. Importantly, human monocytes, monocyte-derived macrophages, and neutrophils exhibit inflammatory features when exposed to subtoxic concentrations of ChA in vitro. ChA increases the secretion of proinflammatory cytokines such as interleukin-1β and interleukin-6 and modulates the surface-marker profile of monocytes and monocyte-derived macrophage. In vivo, when zebrafish larvae were fed with a ChA-enriched diet, they exhibited neutrophil and macrophage accumulation in the vasculature in a caspase 1- and cathepsin B-dependent manner. ChA also triggered lipid accumulation at the bifurcation sites of the vasculature of the zebrafish larvae and negatively impacted their life expectancy. We conclude that ChA behaves as an endogenous damage-associated molecular pattern with inflammatory and proatherogenic properties.
publishDate 2023
dc.date.none.fl_str_mv 2023-09
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://hdl.handle.net/10316/111997
https://hdl.handle.net/10316/111997
https://doi.org/10.1016/j.jlr.2023.100419
url https://hdl.handle.net/10316/111997
https://doi.org/10.1016/j.jlr.2023.100419
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 00222275
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Elsevier
publisher.none.fl_str_mv Elsevier
dc.source.none.fl_str_mv reponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron:RCAAP
instname_str FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron_str RCAAP
institution RCAAP
reponame_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
collection Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository.name.fl_str_mv Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
repository.mail.fl_str_mv info@rcaap.pt
_version_ 1833602567120093184